Vol 8, No 4 (2023)
Letter to the Editor
Published online: 2023-11-14
Glucagon — new formulations as a chance for more effective treatment of severe hypoglycaemia
1
, 1
, 1
DOI: 10.5603/mrj.97466
Medical Research Journal 2023;8(4):328-329.
Abstract
Not available
References
- Schaumleffel C. Pharmacology update: emergency medications for hypoglycemia in diabetes. NASN Sch Nurse. 2021; 36(3): 149–154.
- Zeigerer A, Sekar R, Kleinert M, et al. Glucagon's metabolic action in health and disease. Compr Physiol. 2021; 11(2): 1759–1783.
- Hawkes CP, De Leon DD, Rickels MR. Novel preparations of glucagon for the prevention and treatment of hypoglycemia. Curr Diab Rep. 2019; 19(10): 97.
- Cryer PE. Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. Endocrinology. 2012; 153(3): 1039–1048.
- Story LH, Wilson LM. New developments in glucagon treatment for hypoglycemia. Drugs. 2022; 82(11): 1179–1191.
- Rickels MR, Ruedy KJ, Foster NC, et al. T1D Exchange Intranasal Glucagon Investigators. Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: a randomized crossover noninferiority study. Diabetes Care. 2016; 39(2): 264–270.